Influence of lipid lowering fibrates on P-glycoprotein activity in vitro

This publication has 30 references indexed in Scilit:

• Cerivastatin and Reports of Fatal Rhabdomyolysis
  New England Journal of Medicine, 2002
• Learning from the cerivastatin experience
  The Lancet, 2001
• Plasma concentrations of active simvastatin acid are increased by gemfibrozil
  Clinical Pharmacology & Therapeutics, 2000
• Atorvastatin Coadministration May Increase Digoxin Concentrations by Inhibition of Intestinal P-Glycoprotein-Mediated Secretion
  The Journal of Clinical Pharmacology, 2000
• Potential role of P-glycoprotein in affecting hepatic metabolism of drugs.
  Pharmaceutical Research, 2000
• The Role of P-Glycoprotein and Canalicular Multispecific Organic Anion Transporter in the Hepatobiliary Excretion of Drugs
  Journal of Pharmaceutical Sciences, 1998
• THE PHARMACOLOGICAL ROLE OF P-GLYCOPROTEIN IN THE INTESTINAL EPITHELIUM
  Pharmacological Research, 1998
• Clinical Pharmacokinetics of Fibric Acid Derivatives (Fibrates)
  Clinical Pharmacokinetics, 1998
• Drug Interactions of Lipid-Altering Drugs
  Drug Safety, 1998
• Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
  Published by Elsevier ,1994